BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #16 OF 26 IN HEALTH & PHARMA INTERESTING

BioNTech

· Public · Updated 25 May 2026 11:16 UTC
#295 of 1208 overall by tension · #16 of 26 in Health & Pharma
16 Interesting
The Divergent
Analysis

BioNTech's cultural fade is real (C=46, B=30, sentiment=0.20, -12.71% stock). Post-pandemic, the biotech hero narrative collapsed faster than its equity. Wiki presence absent; narrative exhausted.

IN THE NEWS (66 articles this week)
BNTX Stock Quote Price and Forecast - CNN
ASCO26: After ivonescimab stumble, rivals unveil their own bispecific data - FirstWord Pharma
BioNTech Expands Supervisory Board To Support Oncology Pipeline And Commercial Plans - Yahoo Finance
Cultural Score
46 / 100
Business Score
30 / 100
TENSION▁▁▁▁▁▃▁▁▃▂▂▃▂▂
CULTURAL▄▅▄▄▄▆▄▄▅▄▅▅▄▄
BUSINESS▄▄▄▄▄▄▃▃▃▃▃▂▃▃
Loading...
Wikipedia Momentum 15/40
News Presence 31/35
Search InterestRedistributed to other dimensions
Stock Momentum 8/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
Price$92.14
30d Change-12.7%
Market Cap$23.3B
Profit Margin-44.6%
BioNTech's tension is 16. Culture outpacing commerce. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>